https://www.selleckchem.com/pr....oducts/Mubritinib-TA
Great efforts by the scientific community are rapidly expanding the evidence on the clinical interplay between Covid-19 and inflammatory bowel disease (IBD). We performed a systematic review of the literature on published Covid-19 cases occurring in patients with IBD. PubMed Central/Medline and Embase were systemically searched for records up to May 31, 2020. 13 cohort studies and 5 single case reports were included in the qualitative synthesis. A cumulative number of approximately 800 patients with IBD and Covid-19 were iden
Like
Comment
Share
